The company integrates solar technology into building façade and rooftop surfaces to provide renewable energy generation and offset the operational carbon footprint of buildings. Pic: Getty Images.
- CPV has secured $3m in R&D bridge funding for solar glass technology
- Structured research and development bridge funding from RiverFort Global Opportunities
- Proceeds will be used to advance certification and commercialisation
Special Report: ClearVue Technologies has secured A$3m in structured research and development bridge funding from RiverFort Global Opportunities to advance certification milestones for its solar glass technology.
The company’s glass generates renewable energy onsite while simultaneously delivering superior thermal performance, all without compromising aesthetics.
To anyone inside it still feels like a normal glass window or skylight, but it’s quietly generating solar power.
This funding facility with RiverFort comprises an initial advance of A$1m, with a further A$2m available by mutual agreement. It is secured by CPV’s FY26 R&D tax credit.
“As an existing shareholder this support reflects the clear addressable market growth in this sector and the macro environment clearly strengthening with the increasing global drive to decarbonisation,” RiverFort CEO Gytis Martinkus said.
“ClearVue Technologies (ASX:CPV) has a compelling product portfolio that goes directly to servicing this increasing demand.
“This facility provides the company with access to timely committed capital, and we are excited to partner with ClearVue on the road to commercial success”
Commercialisation already in motion
ClearVue says the non-dilutive funding also protects shareholder value while advancing certifications and driving commercialisation – which is underway with recent deals including the recladding of two of Concept Business Group’s 10-storey commercial towers in South Africa.
“This Facility provides CPV with structured capital at a time when the board views the company as materially undervalued by the market,” CEO and MD Douglas Hunt said.
“Importantly, it enables us to advance critical certification milestones, while protecting existing shareholders from unnecessary dilution at current market levels.
“Our focus remains execution – completing compliance programs, supporting partner deployment and converting active commercial opportunities.
“This funding supports that pathway while preserving and enhancing long-term shareholder value.”
This article was developed in collaboration with ClearVue Technologies, a Stockhead advertiser at the time of publishing.
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
